Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The primary objectives of the study are to evaluate the safety and tolerability of multiple doses of BIIB061 administered to healthy adults. The secondary objective is to determine the multiple-dose PK profile of BIIB061 in this study population.
Key facts
- Study ID
- NCT02228707
- Run by
- Biogen
- People needed
- 56
- Starts
- 2014-08-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2016-06-15
Who can join
Age: 20 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.